Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

CompletedOBSERVATIONAL
Enrollment

715

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

June 17, 2021

Study Completion Date

November 17, 2021

Conditions
Endometriosis and Dysmenorrhea
Interventions
DRUG

BAY86-5300_YAZ-Flex

Patients with endometriosis-associated pelvic pain and/or dysmenorrhea are enrolled solely after the physician's decision of YazFlex treatment in routine clinical practice.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY